Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
4.880
-0.530 (-9.80%)
At close: Nov 28, 2025, 1:00 PM EST
4.860
-0.020 (-0.41%)
After-hours: Nov 28, 2025, 4:52 PM EST
Nephros Market Cap
Nephros has a market cap or net worth of $51.86 million as of November 28, 2025. Its market cap has increased by 199.76% in one year.
Market Cap
51.86M
Enterprise Value
47.84M
1-Year Change
199.76%
Ranking
Category
Stock Price
$4.88
Market Cap Chart
Since September 30, 2004, Nephros's market cap has decreased from $62.30M to $51.86M, a decrease of -16.76%. That is a compound annual growth rate of -0.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 51.90M | 234.84% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 116.39% |
| Dec 31, 2018 | 36.60M | 49.39% |
| Dec 29, 2017 | 24.50M | 36.11% |
| Dec 30, 2016 | 18.00M | 85.57% |
| Dec 31, 2015 | 9.70M | -51.50% |
| Dec 31, 2014 | 20.00M | 163.16% |
| Dec 31, 2013 | 7.60M | -44.93% |
| Dec 31, 2012 | 13.80M | 91.67% |
| Dec 30, 2011 | 7.20M | 71.43% |
| Dec 31, 2010 | 4.20M | -87.08% |
| Dec 31, 2009 | 32.50M | 622.22% |
| Dec 31, 2008 | 4.50M | -27.42% |
| Dec 31, 2007 | 6.20M | -65.36% |
| Dec 29, 2006 | 17.90M | 1.13% |
| Dec 30, 2005 | 17.70M | -69.22% |
| Dec 31, 2004 | 57.50M | -7.70% |
| Sep 30, 2004 | 62.30M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |